No Data
No Data
BofA Trims Price Target on Viatris to $8 From $10
Sector Update: Health Care Stocks Fall Pre-Bell Monday
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Viatris Has Filed Applications To The Ministry Of Health, Labor And Welfare For Approval Of Effexor SR Capsules (Venlafaxine Hydrochloride) For Generalized Anxiety Disorder
Express News | Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of Effexor® for the Treatment of Generalized Anxiety Disorder
Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR for the Treatment of Generalized Anxiety Disorder